3-Hydroxy-piperidinyl-N-benzyl-acyl-arylhydrazone derivatives reduce neuropathic pain and increase thermal threshold mediated by opioid system

Biomed Pharmacother. 2018 Mar:99:492-498. doi: 10.1016/j.biopha.2018.01.077. Epub 2018 Feb 20.

Abstract

Here in, we report the preparation and evaluation of four 3-hydroxy-piperidine-N-benzyl-aryl-acylhydrazone derivatives (6a-d) for their potential antinociceptive activity. In the tail flick test, compounds 6a and 6d exhibited a significant increase in the latency time of the animals, in comparison to the control group. These two compounds also showed a significant increase in the nociceptive threshold from 1 to 6 h after treatment in the CCI neuropathic pain model. In both cases, the antinociceptive activity was blocked by naloxone, suggesting an opioid mechanism of action, but without sedative or motor coordination effects.

Keywords: Antinociceptive activity; N-acylhydrazones; Neuropathic pain; Opioid; Pain.

MeSH terms

  • Analgesics, Opioid / pharmacology
  • Analgesics, Opioid / therapeutic use*
  • Animals
  • Formaldehyde
  • Hydrazones / chemical synthesis
  • Hydrazones / chemistry
  • Hydrazones / pharmacology
  • Hydrazones / therapeutic use*
  • Male
  • Mice
  • Neuralgia / drug therapy*
  • Neuralgia / physiopathology*
  • Pain Threshold* / drug effects
  • Rotarod Performance Test
  • Temperature*

Substances

  • Analgesics, Opioid
  • Hydrazones
  • Formaldehyde